Research & Literature

Effects of non-invasive ventilation on objective sleep and nocturnal respiration in patients with amyotrophic lateral sclerosis.

Boentert M, Brenscheidt I, Glatz C, Young P

Journal of neurology 2015; (262(9)):2073-82 doi:10.1007/s00415-015-7822-4.

Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis.

Kansal K, Mareddy M, Sloane KL, et al.

Dementia and geriatric cognitive disorders 2016; (41(1-2)):109-22 doi:10.1159/000443205.

The frontotemporal dementia-motor neuron disease continuum.

Burrell JR, Halliday GM, Kril JJ, et al.

Lancet (London, England) 2016; (388(10047)):919-31.

Syntactic comprehension deficits across the FTD-ALS continuum.

Kamminga J, Leslie FVC, Hsieh S, et al.

Neurobiology of aging 2016; (41()):11-18 doi:10.1016/j.neurobiolaging.2016.02.002.

Sleep Disturbances in Frontotemporal Dementia.

McCarter SJ, St Louis EK, Boeve BF

Current neurology and neuroscience reports 2016; (16(9)):85 doi:10.1007/s11910-016-0680-3.

Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.

Strong MJ, Abrahams S, Goldstein LH, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2017; (18(3-4)):153-174 doi:10.1080/21678421.2016.1267768.

Dysphagia in Amyotrophic Lateral Sclerosis: Impact on Patient Behavior, Diet Adaptation, and Riluzole Management.

Onesti E, Schettino I, Gori MC, et al.

Frontiers in neurology 2017; (8()):94 doi:10.3389/fneur.2017.00094.

Frontotemporal Dementia.

Olney NT, Spina S, Miller BL

Neurologic clinics 2017; (35(2)):339-374 doi:10.1016/j.ncl.2017.01.008.

A first approach to a neuropsychological screening tool using eye-tracking for bedside cognitive testing based on the Edinburgh Cognitive and Behavioural ALS Screen.

Keller J, Krimly A, Bauer L, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2017; (18(5-6)):443-450 doi:10.1080/21678421.2017.1313869.

Amyotrophic lateral sclerosis or not: Keys for the diagnosis.

Lenglet T, Camdessanché JP

Revue neurologique 2017; (173(5)):280-287 doi:10.1016/j.neurol.2017.04.003.

A Cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival.

Burke T, Pinto-Grau M, Lonergan K, et al.

Annals of clinical and translational neurology 2017; (4(5)):305-317 doi:10.1002/acn3.407.

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.

,

The Lancet. Neurology 2017; (16(7)):505-512 doi:10.1016/S1474-4422(17)30115-1.

Examining the language and behavioural profile in FTD and ALS-FTD.

Saxon JA, Thompson JC, Jones M, et al.

Journal of neurology, neurosurgery, and psychiatry 2017; (88(8)):675-680 doi:10.1136/jnnp-2017-315667.

Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.

Radunovic A, Annane D, Rafiq MK, et al.

The Cochrane database of systematic reviews 2017; (10()):CD004427 doi:10.1002/14651858.CD004427.pub4.

Caregiver burden, sleep quality, depression, and anxiety in dementia caregivers: a comparison of frontotemporal lobar degeneration, dementia with Lewy bodies, and Alzheimer's disease.

Liu S, Liu J, Wang XD, et al.

International psychogeriatrics 2018; (30(8)):1131-1138 doi:10.1017/S1041610217002630.

Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons.

Shi Y, Lin S, Staats KA, et al.

Nature medicine 2018; (24(3)):313-325 doi:10.1038/nm.4490.

Distinct Clinical Features and Outcomes in Motor Neuron Disease Associated with Behavioural Variant Frontotemporal Dementia.

Cortés-Vicente E, Turon-Sans J, Gelpi E, et al.

Dementia and geriatric cognitive disorders 2018; (45(3-4)):220-231 doi:10.1159/000488528.

Communication Matters-Pitfalls and Promise of Hightech Communication Devices in Palliative Care of Severely Physically Disabled Patients With Amyotrophic Lateral Sclerosis.

Linse K, Aust E, Joos M, Hermann A

Frontiers in neurology 2018; (9()):603 doi:10.3389/fneur.2018.00603.

ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS.

Crockford C, Newton J, Lonergan K, et al.

Neurology 2018; (91(15)):e1370-e1380 doi:10.1212/WNL.0000000000006317.

Respiratory muscle testing in amyotrophic lateral sclerosis: a practical approach.

Sferrazza Papa GF, Pellegrino GM, Shaikh H, et al.

Minerva medica 2018; (109(6 Suppl 1)):11-19 doi:10.23736/S0026-4806.18.05920-7.

Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.

Melamed Z, López-Erauskin J, Baughn MW, et al.

Nature neuroscience 2019; (22(2)):180-190 doi:10.1038/s41593-018-0293-z.

Primary progressive aphasia and the FTD-MND spectrum disorders: clinical, pathological, and neuroimaging correlates.

Vinceti G, Olney N, Mandelli ML, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2019; (20(3-4)):146-158 doi:10.1080/21678421.2018.1556695.

Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia-motor neuron disease patients.

Long Z, Irish M, Piguet O, et al.

Journal of neurology 2019; (266(4)):921-933 doi:10.1007/s00415-019-09216-0.

Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder.

Zucchi E, Ticozzi N, Mandrioli J

Frontiers in neuroscience 2019; (13()):175 doi:10.3389/fnins.2019.00175.

Predictors of amyotrophic lateral sclerosis mimic syndrome.

Quarracino C, Segamarchi MC, Rodríguez GE

Acta neurologica Belgica 2019; (119(2)):253-256 doi:10.1007/s13760-019-01135-1.

Interstitial pneumonia and other adverse events in riluzole-administered amyotrophic lateral sclerosis patients: a retrospective observational study.

Inoue-Shibui A, Kato M, Suzuki N, et al.

BMC neurology 2019; (19(1)):72 doi:10.1186/s12883-019-1299-1.

An update on genetic frontotemporal dementia.

Greaves CV, Rohrer JD

Journal of neurology 2019; (266(8)):2075-2086 doi:10.1007/s00415-019-09363-4.

Optimizing the noninvasive ventilation pathway for patients with amyotrophic lateral sclerosis/motor neuron disease: a systematic review.

Baxter SK, Johnson M, Clowes M, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2019; (20(7-8)):461-472 doi:10.1080/21678421.2019.1627372.

Schizophrenia Phenotype Preceding Behavioral Variant Frontotemporal Dementia Related to C9orf72 Repeat Expansion.

Sellami L, St-Onge F, Poulin S, Laforce R

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2019; (32(2)):120-123 doi:10.1097/WNN.0000000000000189.

Cognitive impairment across ALS clinical stages in a population-based cohort.

Chiò A, Moglia C, Canosa A, et al.

Neurology 2019; (93(10)):e984-e994 doi:10.1212/WNL.0000000000008063.

A Comprehensive Examination of Percutaneous Endoscopic Gastrostomy and Its Association with Amyotrophic Lateral Sclerosis Patient Outcomes.

Bond L, Ganguly P, Khamankar N, et al.

Brain sciences 2019; (9(9)) doi:10.3390/brainsci9090223.

Riluzole Oral Suspension: Bioavailability Following Percutaneous Gastrostomy Tube-modeled Administration Versus Direct Oral Administration.

Brooks BR, Bettica P, Cazzaniga S

Clinical therapeutics 2019; (41(12)):2490-2499 doi:10.1016/j.clinthera.2019.09.016.

COG-01 Phenotypic variation in 
ALS-FTD and effect on survival.

Ahmed RM, Devenney EM, Strikwerda-Brown C, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2019; (20(sup1)):301-308 doi:10.1080/21678421.2019.1647000.

Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers: A Systematic Review and Meta-analysis.

Glasmacher SA, Wong C, Pearson IE, Pal S

JAMA neurology 2020; (77(3)):367-376 doi:10.1001/jamaneurol.2019.3924.

The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta-analysis.

Forgrave LM, Ma M, Best JR, DeMarco ML

Alzheimer's & dementia (Amsterdam, Netherlands) 2019; (11()):730-743 doi:10.1016/j.dadm.2019.08.009.

The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis.

Huynh W, Ahmed R, Mahoney CJ, et al.

Expert review of neurotherapeutics 2020; (20(3)):281-293 doi:10.1080/14737175.2020.1727740.

Top Ten Tips Palliative Care Clinicians Should Know About Amyotrophic Lateral Sclerosis.

Everett EA, Pedowitz E, Maiser S, et al.

Journal of palliative medicine 2020; (23(6)):842-847 doi:10.1089/jpm.2020.0046.

Phenotypic variability in ALS-FTD and effect on survival.

Ahmed RM, Devenney EM, Strikwerda-Brown C, et al.

Neurology 2020; (94(19)):e2005-e2013 doi:10.1212/WNL.0000000000009398.

Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study.

Bersano E, Sarnelli MF, Solara V, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2020; (21(5-6)):373-379 doi:10.1080/21678421.2020.1771732.

Amyotrophic lateral sclerosis: a clinical review.

Masrori P, Van Damme P

European journal of neurology 2020; (27(10)):1918-1929 doi:10.1111/ene.14393.

Which are the factors influencing NIV adaptation and tolerance in ALS patients?

Russo M, Bonanno C, Profazio C, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(3)):1023-1029 doi:10.1007/s10072-020-04624-x.

Cognitive and behavioural impairment in amyotrophic lateral sclerosis.

Pender N, Pinto-Grau M, Hardiman O

Current opinion in neurology 2020; (33(5)):649-654 doi:10.1097/WCO.0000000000000862.

C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy.

Cook CN, Wu Y, Odeh HM, et al.

Science translational medicine 2020; (12(559)) doi:10.1126/scitranslmed.abb3774.

Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care System.

Vu M, Tortorice K, Zacher J, et al.

JAMA network open 2020; (3(10)):e2014645 doi:10.1001/jamanetworkopen.2020.14645.

Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis.

Saxon JA, Thompson JC, Harris JM, et al.

Journal of neurology, neurosurgery, and psychiatry 2020; (91(12)):1304-1311 doi:10.1136/jnnp-2020-323969.

Palliative Care Consults in an Inpatient Setting for Patients With Amyotrophic Lateral Sclerosis.

Mehta AK, Jackson NJ, Wiedau-Pazos M

The American journal of hospice & palliative care 2021; (38(9)):1091-1098 doi:10.1177/1049909120969959.

Screening for cognition in amyotrophic lateral sclerosis: test characteristics of a new screen.

Beeldman E, Govaarts R, de Visser M, et al.

Journal of neurology 2021; (268(7)):2533-2540 doi:10.1007/s00415-021-10423-x.

Heterogeneity of behavioural and language deficits in FTD-MND.

Long Z, Irish M, Foxe D, et al.

Journal of neurology 2021; (268(8)):2876-2889 doi:10.1007/s00415-021-10451-7.

Cerebrospinal Fluid and Blood Neurofilament Light Chain Protein in Prion Disease and Other Rapidly Progressive Dementias: Current State of the Art.

Abu-Rumeileh S, Parchi P

Frontiers in neuroscience 2021; (15()):648743 doi:10.3389/fnins.2021.648743.

The impact of cognitive decline in amyotrophic lateral sclerosis on swallowing. A scoping review.

Francis R, Attrill S, Doeltgen S

International journal of speech-language pathology 2021; (23(6)):604-613 doi:10.1080/17549507.2021.1894235.

Cognitive and Behavioral Manifestations in ALS: Beyond Motor System Involvement.

Rusina R, Vandenberghe R, Bruffaerts R

Diagnostics (Basel, Switzerland) 2021; (11(4)) doi:10.3390/diagnostics11040624.

Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.

Root J, Merino P, Nuckols A, et al.

Neurobiology of disease 2021; (154()):105360 doi:10.1016/j.nbd.2021.105360.

Awaji criteria for the diagnosis of amyotrophic lateral sclerosis in Hanoi, Vietnam.

Van Nguyen T, Tran TA, Vu HT

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(1)):393-398 doi:10.1007/s10072-021-05333-9.

Motor neuron disease beginning with frontotemporal dementia: clinical features and progression.

Gromicho M, Kuzma-Kozakiewicz M, Szacka K, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2021; (22(7-8)):508-516 doi:10.1080/21678421.2021.1910309.

Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS.

Halbgebauer S, Steinacker P, Verde F, et al.

Journal of neurology, neurosurgery, and psychiatry 2022; (93(1)):68-74 doi:10.1136/jnnp-2021-327129.

Correlations between measures of ALS respiratory function: is there an alternative to FVC?

Murray D, Rooney J, Al-Chalabi A, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2021; (22(7-8)):495-504 doi:10.1080/21678421.2021.1908362.

Embedded Psychiatric Services in a Multidisciplinary Amyotrophic Lateral Sclerosis Clinic: An Assessment of Patient Needs and Perceptions.

Hardy M, Castle C, Jackson C

The Journal of neuropsychiatry and clinical neurosciences 2022; (34(1)):53-59 doi:10.1176/appi.neuropsych.21040092.

Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics.

Behzadi A, Pujol-Calderón F, Tjust AE, et al.

Scientific reports 2021; (11(1)):22128 doi:10.1038/s41598-021-01499-6.

Tackling clinical heterogeneity across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum using a transdiagnostic approach.

Ahmed RM, Bocchetta M, Todd EG, et al.

Brain communications 2021; (3(4)):fcab257 doi:10.1093/braincomms/fcab257.

Loss of "insight" into behavioral changes in ALS: Differences across cognitive profiles.

Temp AGM, Kasper E, Vielhaber S, et al.

Brain and behavior 2022; (12(1)):e2439 doi:10.1002/brb3.2439.

Percutaneous endoscopic gastrostomy using the introducer method with ultra-slim endoscopy in amyotrophic lateral sclerosis patients with respiratory compromise: A safe technique.

Chuah KH, Yim CCW, Abdul Aziz NA, et al.

Journal of gastroenterology and hepatology 2022; (37(7)):1367-1372 doi:10.1111/jgh.15870.

Oropharyngeal Dysphagia as the Main Expression of Amyotrophic Lateral Sclerosis.

Rugaitienė M, Damulevičienė G, Lesauskaitė V, Ulozienė I

Medicina (Kaunas, Lithuania) 2022; (58(5)) doi:10.3390/medicina58050647.

Distinct disease trajectories in frontotemporal dementia-motor neuron disease and behavioural variant frontotemporal dementia: A longitudinal study.

Long Z, Irish M, Hodges JR, et al.

European journal of neurology 2022; (29(11)):3158-3169 doi:10.1111/ene.15518.

Primary progressive aphasia and motor neuron disease: A review.

Aiello EN, Feroldi S, De Luca G, et al.

Frontiers in aging neuroscience 2022; (14()):1003792 doi:10.3389/fnagi.2022.1003792.

A recent survey of augmentative and alternative communication use and service delivery experiences of people with amyotrophic lateral sclerosis in the United States.

Peters B, O'Brien K, Fried-Oken M

Disability and rehabilitation. Assistive technology 2024; (19(4)):1121-1134 doi:10.1080/17483107.2022.2149866.

Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis.

Gao M, Zhu L, Chang J, et al.

Clinical drug investigation 2023; (43(1)):1-11 doi:10.1007/s40261-022-01229-4.

Palliative care principles in ALS.

Shoesmith C

Handbook of clinical neurology 2023; (191()):139-155 doi:10.1016/B978-0-12-824535-4.00007-0.

Respiratory phenotypes in amyotrophic lateral sclerosis as determined by respiratory questions on the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised and their relation to respiratory tests.

Pinto S, Oliveira Santos M, Gromicho M, et al.

European journal of neurology 2023; (30(6)):1594-1599 doi:10.1111/ene.15765.

Effects of Aided Communication on Communicative Participation for People With Amyotrophic Lateral Sclerosis.

Peters B, Wiedrick J, Baylor C

American journal of speech-language pathology 2023; (32(4)):1450-1465 doi:10.1044/2023_AJSLP-22-00346.

Loss of TDP-43 oligomerization or RNA binding elicits distinct aggregation patterns.

Pérez-Berlanga M, Wiersma VI, Zbinden A, et al.

The EMBO journal 2023; (42(17)):e111719 doi:10.15252/embj.2022111719.

The involvement of language-associated networks, tracts, and cortical regions in frontotemporal dementia and amyotrophic lateral sclerosis: Structural and functional alterations.

Tahedl M, Tan EL, Chipika RH, et al.

Brain and behavior 2023; (13(11)):e3250 doi:10.1002/brb3.3250.

Airway Clearance Strategies and Secretion Management in Amyotrophic Lateral Sclerosis.

McHenry KL

Respiratory care 2024; (69(2)):227-237 doi:10.4187/respcare.11215.

Temporal course of cognitive and behavioural changes in motor neuron diseases.

McHutchison CA, Wuu J, McMillan CT, et al.

Journal of neurology, neurosurgery, and psychiatry 2024; (95(4)):316-324 doi:10.1136/jnnp-2023-331697.

G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons.

Rothstein JD, Baskerville V, Rapuri S, et al.

Acta neuropathologica 2023; (147(1)):1 doi:10.1007/s00401-023-02652-3.

What is the extent of reliability and validity evidence for screening tools for cognitive and behavioral change in people with ALS? A systematic review.

Didcote L, Vitoratou S, Al-Chalabi A, Goldstein LH

Amyotrophic lateral sclerosis & frontotemporal degeneration 2024; (25(5-6)):437-451 doi:10.1080/21678421.2024.2314063.

Edaravone Oral Suspension: A Neuroprotective Agent to Treat Amyotrophic Lateral Sclerosis.

Singh P, Belliveau P, Towle J, et al.

American journal of therapeutics 2024; (31(3)):e258-e267 doi:10.1097/MJT.0000000000001742.

Amyotrophic lateral sclerosis; clinical features, differential diagnosis and pathology.

Van Es MA

International review of neurobiology 2024; (176()):1-47 doi:10.1016/bs.irn.2024.04.011.

High levels of neurofilament light and YKL-40 in cerebrospinal fluid are related to poor outcome in ALS.

Rosén C, Mitre B, Nellgård B, et al.

Journal of the neurological sciences 2024; (463()):123112 doi:10.1016/j.jns.2024.123112.

Treatment continuity of amyotrophic lateral sclerosis with available riluzole formulations: state of the art and current challenges in a 'real-world' setting.

Corcia P, Guy N, Pradat PF, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2025; (26(1-2)):15-21 doi:10.1080/21678421.2024.2375330.

Juvenile Amyotrophic Lateral Sclerosis: A Case Report of a Rare and Aggressive Presentation in a 22-Year-Old Filipino Male.

Po K, Olaivar M

Cureus 2024; (16(9)):e68579 doi:10.7759/cureus.68579.

Clinical and imaging correlates of hyperorality in syndromes associated with frontotemporal lobar degeneration.

Altomare D, Bracca V, Premi E, et al.

Psychiatry and clinical neurosciences 2024; (78(12)):818-825 doi:10.1111/pcn.13751.

Clinical usefulness of the Verbal Fluency Index (VFI) in amyotrophic lateral sclerosis.

Aiello EN, Curti B, Torre S, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(2)):775-782 doi:10.1007/s10072-024-07789-x.

Provision, cough efficacy and treatment satisfaction of mechanical insufflation-exsufflation in a large multicenter cohort of patients with amyotrophic lateral sclerosis.

Maier A, Kettemann D, Weyen U, et al.

Scientific reports 2025; (15(1)):7360 doi:10.1038/s41598-025-91692-8.

Cognitive capacity in amyotrophic lateral sclerosis: the value of diagnostic markers in cerebrospinal fluid and the influence of nutrition and pulmonary function.

Wölfel SM, Widmann CN, Castro-Gomez S, et al.

Brain communications 2025; (7(2)):fcaf137 doi:10.1093/braincomms/fcaf137.

Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study MT-1186-A02).

Rothstein J, Genge A, De Silva S, et al.

Muscle & nerve 2025; (72(3)):433-442 doi:10.1002/mus.28448.

The Differential Effects of Genetic Mutations in ALS and FTD Genes on Behavioural and Cognitive Changes: A Systematic Review and Meta-Analysis.

Jiménez-García AM, Tortorella ME, Nishimura AL, Arias N

International journal of molecular sciences 2025; (26(13)) doi:10.3390/ijms26136199.

Neurofilament Light Chain and Differentiation of Behavioral Variant Frontotemporal Dementia From Psychiatric Disorders: A Systematic Review.

Davydow DS, Brasfield M, Morrow CB, et al.

JAMA psychiatry 2026; (83(1)):85-98 doi:10.1001/jamapsychiatry.2025.2429.

Pan-Asian consortium for treatment and research in ALS (PACTALS) guidelines for management of amyotrophic lateral sclerosis.

Vucic S, Shahrizaila N, Kano O, et al.

The Lancet regional health. Western Pacific 2025; (62()):101684 doi:10.1016/j.lanwpc.2025.101684.

Clinical Changes in Patients With Amyotrophic Lateral Sclerosis Admitted to a Home Care Program.

Mercadante S, Petronaci A, Casuccio A

Journal of pain and symptom management 2026; (71(4)):560-566 doi:10.1016/j.jpainsymman.2025.12.026.

Stage-Based Communication Rehabilitation in Amyotrophic Lateral Sclerosis (ALS): A Review of Strategies for Enhancing Quality of Life.

Jackson MC, Azarraga RB, Fraix MP, Agrawal DK

Archives of internal medicine research 2025; (8(4)):359-371 doi:10.26502/aimr.0230.

Blocking RAN translation without altering repeat RNAs rescues C9ORF72-related ALS and FTD phenotypes.

Jiang X, Schaeffer L, Patni D, et al.

Science (New York, N.Y.) 2026; (391(6785)):eadv2600 doi:10.1126/science.adv2600.

Safety of Intravenous Edaravone in Clinical Practice.

Genge A, Apple S

Muscle & nerve 2026; (73 Suppl 1()):S13-S15 doi:10.1002/mus.70038.

Amyotrophic lateral sclerosis and degenerative cervical myelopathy: phenotype-based diagnostic pitfalls, investigative mismatch, and practical clinical reasoning.

Chen D, Shen T, Ren H, Qiu P

Frontiers in neurology 2026; (17()):1901811 doi:10.3389/fneur.2026.1901811.